Giulio Bevilacqua | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy	CANCERS	2024
The Current Role of Contrast-Enhanced Ultrasound (CEUS) in the Diagnosis and Staging of Bladder Cancer: A Review of the Available Literature	LIFE	2024
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience	CANCERS	2024
Protein corona on nanoparticles for tumor targeting in prostate cancer. Review of the literature and experimental trial protocol	BIOLOGY	2024
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review	ASIAN JOURNAL OF UROLOGY	2023
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance	CURRENT ISSUES IN MOLECULAR BIOLOGY	2023
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?	CURRENT ONCOLOGY	2023
INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION	CLINICAL GENITOURINARY CANCER	2023
Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature	CANCERS	2023
How to predict outcomes from a biofeedback and pelvic floor muscle electric stimulation program in patients with urinary incontinence after radical prostatectomy	JOURNAL OF CLINICAL MEDICINE	2022
Comment on: Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis	MINERVA UROLOGY AND NEPHROLOGY	2022
Regenerative medicine-based treatment of stress urinary incontinence with stem cells: a systematic review and meta-analysis	CURRENT STEM CELL RESEARCH & THERAPY	2022
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy	ADVANCES IN UROLOGY	2022
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer	CURRENT ONCOLOGY	2022
How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives	MINERVA UROLOGY AND NEPHROLOGY	2022

Gruppi di ricerca

Regenerative medicine-based treatment with injection of autologous muscle-derived or adipose-derived stem cells for the management of stress urinary incontinence : two preclinical models